EW vs KAI · P/E 47, rev $1.39B vs P/E 36, rev $1.05B
Edwards Lifesciences Corp (EW) versus Kadant Inc (KAI) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Kadant Inc (KAI) is a specialty industrial machinery company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported KAI revenue for 2024-12-28 was $1.05B. Net income was $112.6M. Revenue was up 10.0% from 2023-12-30 to 2024-12-28. KAI currently screens at market cap $3.69B and trailing P/E 35.6.
EW currently screens at market cap $49.91B and trailing P/E 46.9. KAI currently screens at market cap $3.69B and trailing P/E 35.6.
Not investment advice. Open the EW and KAI stock pages for the full models.
Not investment advice.